203 related articles for article (PubMed ID: 32378660)
1. [Drug Delivery to Various Body Organs via Non-blood Circulatory Pathway].
Kogure K; Fukuta T
Yakugaku Zasshi; 2020; 140(5):611-615. PubMed ID: 32378660
[TBL] [Abstract][Full Text] [Related]
2. Iontophoresis-mediated direct delivery of nucleic acid therapeutics, without use of carriers, to internal organs via non-blood circulatory pathways.
Hasan M; Fukuta T; Inoue S; Mori H; Kagawa M; Kogure K
J Control Release; 2022 Mar; 343():392-399. PubMed ID: 35131371
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive delivery of biological macromolecular drugs into the skin by iontophoresis and its application to psoriasis treatment.
Fukuta T; Oshima Y; Michiue K; Tanaka D; Kogure K
J Control Release; 2020 Jul; 323():323-332. PubMed ID: 32360305
[TBL] [Abstract][Full Text] [Related]
4. Overcoming thickened pathological skin in psoriasis via iontophoresis combined with tight junction-opening peptide AT1002 for intradermal delivery of NF-κB decoy oligodeoxynucleotide.
Fukuta T; Tanaka D; Inoue S; Michiue K; Kogure K
Int J Pharm; 2021 Jun; 602():120601. PubMed ID: 33905867
[TBL] [Abstract][Full Text] [Related]
5. Faint electric treatment-induced rapid and efficient delivery of extraneous hydrophilic molecules into the cytoplasm.
Hasan M; Nishimoto A; Ohgita T; Hama S; Kashida H; Asanuma H; Kogure K
J Control Release; 2016 Apr; 228():20-25. PubMed ID: 26944781
[TBL] [Abstract][Full Text] [Related]
6. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics.
Dahlman JE; Kauffman KJ; Xing Y; Shaw TE; Mir FF; Dlott CC; Langer R; Anderson DG; Wang ET
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2060-2065. PubMed ID: 28167778
[TBL] [Abstract][Full Text] [Related]
7. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
Takeuchi I; Takeshita T; Suzuki T; Makino K
Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
[TBL] [Abstract][Full Text] [Related]
8. Electric stimulus opens intercellular spaces in skin.
Hama S; Kimura Y; Mikami A; Shiota K; Toyoda M; Tamura A; Nagasaki Y; Kanamura K; Kajimoto K; Kogure K
J Biol Chem; 2014 Jan; 289(4):2450-6. PubMed ID: 24318878
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting.
Palmer BC; DeLouise LA
Molecules; 2016 Dec; 21(12):. PubMed ID: 27983701
[TBL] [Abstract][Full Text] [Related]
10. Electrically assisted delivery of macromolecules into the corneal epithelium.
Hao J; Li SK; Liu CY; Kao WW
Exp Eye Res; 2009 Dec; 89(6):934-41. PubMed ID: 19682448
[TBL] [Abstract][Full Text] [Related]
11. Iontophoresis-based transdermal delivery systems.
Kanikkannan N
BioDrugs; 2002; 16(5):339-47. PubMed ID: 12408738
[TBL] [Abstract][Full Text] [Related]
12. Iontophoretic delivery of lipophilic and hydrophilic drugs from lipid nanoparticles across human skin.
Charoenputtakun P; Li SK; Ngawhirunpat T
Int J Pharm; 2015 Nov; 495(1):318-328. PubMed ID: 26325320
[TBL] [Abstract][Full Text] [Related]
13. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
[TBL] [Abstract][Full Text] [Related]
14. To be targeted: is the magic bullet concept a viable option for synthetic nucleic acid therapeutics?
Ogris M; Wagner E
Hum Gene Ther; 2011 Jul; 22(7):799-807. PubMed ID: 21563983
[TBL] [Abstract][Full Text] [Related]
15. Iontophoresis of Biological Macromolecular Drugs.
Hasan M; Khatun A; Kogure K
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335900
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
Xu L; Anchordoquy T
J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis.
Park J; Lee H; Lim GS; Kim N; Kim D; Kim YC
AAPS PharmSciTech; 2019 Jan; 20(3):96. PubMed ID: 30694397
[TBL] [Abstract][Full Text] [Related]
18. Non-viral nucleic acid containing nanoparticles as cancer therapeutics.
Kozielski KL; Rui Y; Green JJ
Expert Opin Drug Deliv; 2016 Oct; 13(10):1475-87. PubMed ID: 27248202
[TBL] [Abstract][Full Text] [Related]
19. Use of Iontophoresis Technology for Transdermal Delivery of a Minimal mRNA Vaccine as a Potential Melanoma Therapeutic.
Husseini RA; Abe N; Hara T; Abe H; Kogure K
Biol Pharm Bull; 2023; 46(2):301-308. PubMed ID: 36724958
[TBL] [Abstract][Full Text] [Related]
20. Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer.
Hsu T; Mitragotri S
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15816-21. PubMed ID: 21903933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
